Cargando…

Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence

BACKGROUND: Embelin, a quinone derivative, is found in the fruits of Embelia ribes Burm (Myrsinaceae). It has been shown to have a variety of therapeutic potentials including anthelmintic, anti-tumor, anti-diabetic, anti-bacterial and anti-inflammation. Inflammation is an immunological response to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhanjal, Jaspreet Kaur, Nigam, Nupur, Sharma, Sudhanshu, Chaudhary, Anupama, Kaul, Sunil C, Grover, Abhinav, Wadhwa, Renu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210574/ https://www.ncbi.nlm.nih.gov/pubmed/25336399 http://dx.doi.org/10.1186/1471-2407-14-775

Ejemplares similares

Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
por: Nigam, Nupur, et al.
Publicado: (2015)

Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
por: Wadhwa, Renu, et al.
Publicado: (2016)

Bioinformatics and Molecular Insights to Anti-Metastasis Activity of Triethylene Glycol Derivatives
por: Malik, Vidhi, et al.
Publicado: (2020)

Structural insights into mode of actions of novel natural Mycobacterium protein tyrosine phosphatase B inhibitors
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2014)

Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular Evidence
por: Garg, Sukant, et al.
Publicado: (2019)

Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and Mortaparib(Plus)
por: Kumar, Vipul, et al.
Publicado: (2021)

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
por: Putri, Jayarani F., et al.
Publicado: (2019)

Identification and Characterization of Mortaparib(Plus)—A Novel Triazole Derivative That Targets Mortalin-p53 Interaction and Inhibits Cancer-Cell Proliferation by Wild-Type p53-Dependent and -Independent Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2021)

Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility
por: Vats, Chakshu, et al.
Publicado: (2015)

Mutant p53(L194F) Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to Mortaparib(Plus), a Multimodal Small Molecule Inhibitor
por: Elwakeel, Ahmed, et al.
Publicado: (2021)

Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2021)

Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53(Y220C) mutant: bioinformatics and experimental evidence
por: Radhakrishnan, Navaneethan, et al.
Publicado: (2021)

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1
por: Meidinna, Hazna Noor, et al.
Publicado: (2022)

2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences
por: Chaudhary, Anupama, et al.
Publicado: (2019)

Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin
por: Tyagi, Chetna, et al.
Publicado: (2014)

Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus
por: Grover, Sonam, et al.
Publicado: (2014)

Mechanistic insights into mode of action of novel natural cathepsin L inhibitors
por: Tyagi, Chetna, et al.
Publicado: (2013)

Combinations of Ashwagandha Leaf Extracts Protect Brain-Derived Cells against Oxidative Stress and Induce Differentiation
por: Shah, Navjot, et al.
Publicado: (2015)

Wild type p53 function in p53(Y220C) mutant harboring cells by treatment with Ashwagandha derived anticancer withanolides: bioinformatics and experimental evidence
por: Sundar, Durai, et al.
Publicado: (2019)

Novel Natural Structure Corrector of ApoE4 for Checking Alzheimer's Disease: Benefits from High Throughput Screening and Molecular Dynamics Simulations
por: Goyal, Manisha, et al.
Publicado: (2013)

Development of Dual Inhibitors against Alzheimer's Disease Using Fragment-Based QSAR and Molecular Docking
por: Goyal, Manisha, et al.
Publicado: (2014)

Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
por: Sari, Anissa Nofita, et al.
Publicado: (2020)

A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms
por: Sari, Anissa Nofita, et al.
Publicado: (2022)

Modulation of Diacylglycerol-Induced Melanogenesis in Human Melanoma and Primary Melanocytes: Role of Stress Chaperone Mortalin
por: Wadhwa, Renu, et al.
Publicado: (2019)

Stress Degradation Studies on Embelin
por: Ferreira, Galvina, et al.
Publicado: (2013)

The Application of Embelin for Cancer Prevention and Therapy †
por: Ko, Jeong-Hyeon, et al.
Publicado: (2018)

Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
por: Saxena, Nishant, et al.
Publicado: (2013)

Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2
por: Dhanjal, Jaspreet Kaur, et al.
Publicado: (2015)

Ashwagandha Derived Withanone Targets TPX2-Aurora A Complex: Computational and Experimental Evidence to its Anticancer Activity
por: Grover, Abhinav, et al.
Publicado: (2012)

Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity
por: Kataria, Hardeep, et al.
Publicado: (2012)

Withania somnifera Water Extract as a Potential Candidate for Differentiation Based Therapy of Human Neuroblastomas
por: Kataria, Hardeep, et al.
Publicado: (2013)

Ceramide Kinase Regulates the Production of Tumor Necrosis Factor α (TNFα) via Inhibition of TNFα-converting Enzyme
por: Lamour, Nadia F., et al.
Publicado: (2011)

Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity
por: Lee, Eun-Jung, et al.
Publicado: (2014)

Design, synthesis and α-glucosidase inhibition study of novel embelin derivatives
por: Chen, Xiaole, et al.
Publicado: (2020)

CARF enrichment promotes epithelial–mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target
por: Kalra, Rajkumar S., et al.
Publicado: (2018)

XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
por: Wehrkamp, Cody J., et al.
Publicado: (2014)

Embelin binds to human neuroserpin and impairs its polymerisation
por: Saga, Giorgia, et al.
Publicado: (2016)

Anti-plasmodial and Chloroquine Resistance Suppressive Effects of Embelin
por: Zaid, O.I., et al.
Publicado: (2017)

Embelin as Lead Compound for New Neuroserpin Polymerization Inhibitors
por: Visentin, Cristina, et al.
Publicado: (2020)

Pharmacological evaluation of embelin - chitosan nanoparticles as an antidiabetic agent
por: Maanvizhi, Saba, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aarkr6vkthjah4fohrica6krgs